Ginoza Margaret E C, Isasi Rosario
University of Miami Miller School of Medicine, Miami, Florida 33136, USA.
Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami Miller School of Medicine, Miami, Florida 33136, USA.
Cold Spring Harb Perspect Med. 2020 May 1;10(5):a036681. doi: 10.1101/cshperspect.a036681.
Preimplantation genetic testing (PGT) is a reproductive technology that, in the course of in vitro fertilization (IVF), allows prospective parents to select their future offspring based on genetic characteristics. PGT could be seen as an exercise of reproductive liberty, thus potentially raising significant socioethical and legal controversy. In this review, we examine-from a comparative perspective-variations in policy approaches to the regulation of PGT. We draw on a sample of 19 countries (Australia, Austria, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Italy, Japan, Mexico, Netherlands, Singapore, South Korea, Switzerland, United Kingdom, and the United States) to provide a global landscape of the spectrum of policy and legislative approaches (e.g., restrictive to permissive, public vs. private models). We also explore central socioethical and policy issues and contentious applications, including permissibility criteria (e.g., medical necessity), nonmedical sex selection, and reproductive tourism. Finally, we further outline genetic counseling requirements across policy approaches.
植入前基因检测(PGT)是一种生殖技术,在体外受精(IVF)过程中,它使准父母能够根据基因特征选择未来的后代。PGT可被视为一种生殖自由的行为,因此可能引发重大的社会伦理和法律争议。在本综述中,我们从比较的角度审视了PGT监管政策方法的差异。我们选取了19个国家(澳大利亚、奥地利、比利时、巴西、加拿大、中国、法国、德国、印度、以色列、意大利、日本、墨西哥、荷兰、新加坡、韩国、瑞士、英国和美国)作为样本,以呈现政策和立法方法范围的全球概况(例如,从限制到许可,公共模式与私人模式)。我们还探讨了核心的社会伦理和政策问题以及有争议的应用,包括许可标准(如医疗必要性)、非医学性别选择和生殖旅游。最后,我们进一步概述了不同政策方法下的遗传咨询要求。